Literature DB >> 909056

Dilatation of the mesenteric vascular bed of the dog produced by a peptide, urotensin I.

K MacCannell, K Lederis.   

Abstract

Urotensin I, a peptide derived from the urophysis of bony fish, produced hypotension when administered intravenously in small doses to pentobarbital-anesthetized dogs. The mechanism of this hypotensive response was mainly, if not exclusively, due to dilatation of the cephalic and caudal mesenteric arteries. Neither the hypotensive response nor the mesenteric vasodilator response was prevented by adrenergic, histaminergic or muscarinic receptor blockade. In the doses employed, urotensin I constantly caused minimal increases in heart rate and left ventricular dp/dt; these changes could be prevented by prior administration of propranolol, indicating that they were probably reflex in origin. The authors suggest that the unique mechanism of action of the peptide may make it a valuable tool in studies of the mesenteric circulation, particularly in experimental shock; moreover, the peptide may prove useful in situations in which afterload reduction in the absence of cardiac stimulation is desired.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 909056

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog.

Authors:  B S Gan; K L MacCannell; M D Hollenberg
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

2.  Urotensin I-CRF-Urocortins: a mermaid's tail.

Authors:  Quentin J Pittman; Morley D Hollenberg
Journal:  Gen Comp Endocrinol       Date:  2009-05-04       Impact factor: 2.822

3.  Immunocytochemical localization of urotensin I neurons in the caudal neurosecretory system of the white sucker (Catostomus commersoni).

Authors:  A W Fisher; K Wong; V Gill; K Lederis
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

4.  Corticotropin-releasing factor (CRF)-like immunoreactivity in the vertebrate endocrine pancreas.

Authors:  P Petrusz; I Merchenthaler; J L Maderdrut; S Vigh; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.